DR. GLENN L ZELLMAN MD
NPI 1285611582
Dermatology - Procedural Dermatology in Phoenix, AZ

Active since December 28, 2005PECOS EnrolledAccepts Medicare Assignment
63/100
CMS Quality Rating
2224 W NORTHERN AVE STE D300, PHOENIX, AZ 85021(602) 277-1449(602) 277-9984 Get Directions Write a Review

NPPES record last updated: October 24, 2018. Verified against the NPPES registry weekly; last sync: August 02, 2026.

About Dr. Glenn L Zellman Md NPPES

Official registry information on file with the National Plan and Provider Enumeration System.

DR. GLENN L ZELLMAN MD (NPI 1285611582) is an individual procedural dermatology provider in Phoenix, Arizona, licensed in Florida (ME0072954) and active in the NPI registry since December 2005. He is enrolled in Medicare PECOS, maintains a secondary practice location in Tamarac, and is a graduate of Duke University School Of Medicine (1993).

NPPES Registry Identity

NPI1285611582
Entity TypeIndividualMale
Primary Taxonomy207NS0135X
Provider Legal NameDR. GLENN L ZELLMANCredential: MD
Location Address2224 W NORTHERN AVE STE D300Phoenix, AZ 85021
Mailing Address2224 W Northern Ave Ste D300Phoenix, AZ 85021-5099 · (602) 277-1449 · Fax (602) 277-9984
Fax(602) 277-9984
Sole ProprietorNo
Medical School CMSDuke University School Of MedicineGraduated 1993
Enumeration DateDecember 28, 2005
Last NPPES UpdateOctober 24, 2018
NPI 1285611582 is a valid, active identifier and passes the ISO check-digit test.

Specialties & Licenses

Primary SpecialtyDermatology · Procedural DermatologyAllopathic & Osteopathic Physicians
Taxonomy Code207NS0135X
License Licensed in FL · ME0072954
Definition
Procedural Dermatology, a subspecialty of Dermatology, encompassing a wide variety of surgical procedures and methods to remove or modify skin tissue for health or cosmetic benefit. These methods include scalpel surgery, laser surgery, chemical surgery, cryosurgery (liquid nitrogen), electrosurgery, aspiration surgery, liposuction, injection of filler substances, and Mohs micrographic controlled surgery (a special technique for the removal of growths, especially skin cancers).
2224 W NORTHERN AVE STE D300, Phoenix, AZ 85021

Secondary Practice Location 1

Location 17301 N University Dr, suite102Tamarac, FL 33321-2919 · Phone (954) 726-2000 · Fax (954) 726-3109

Accepted Insurance

Medicare Participation & PECOS CMS

Medicare enrollment, assignment, and ordering and referring status from the CMS PECOS system.

Medicare Enrollment Status

Enrolled in Medicare and accepts Medicare assignment

Dr. Glenn L Zellman Md is registered in PECOS and agrees to accept the Medicare-approved amount as full payment. Medicare patients are not billed beyond the standard deductible and coinsurance.

PECOS PAC ID9436344405
PECOS Enrollment IDI20151028001615
Eligible to Order & Refer Part B Labs & Imaging Durable Medical Equipment Home Health Agency Power Mobility DevicesPer the CMS Ordering and Referring file. Eligibility means Medicare pays claims that this provider orders or refers for these categories.

Areas of Expertise CMS Part B claims 23

Services this provider delivered to Medicare fee-for-service patients, from the CMS Medicare utilization data. Higher counts generally reflect more experience with a service; care delivered outside Medicare is not included.

Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg J7345
Aminolevulinic acid hcl is a topical gel used to treat certain skin conditions. It works by making affected skin cells more sensitive to light, which is then used to destroy these cells. The gel is applied by a healthcare professional.
17,400 services81 patients
Destruction of precancer skin growth, 2-14 growths 17003
This procedure involves removing 2-14 precancerous skin growths. The growths are treated to prevent them from potentially developing into skin cancer. The process is safe, with minimal discomfort, and promotes healthier skin.
1,430 services326 patients
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more 99213
This is a routine visit for patients who have already been seen by the healthcare provider. During this approximately 20-29 minute appointment, your health status will be evaluated and any necessary treatments or tests will be discussed. It's a chance to address any health concerns you may have.
1,073 services687 patients
Destruction of precancer skin growth, 1 growth 17000
"Destruction of precancer skin growth" is a procedure that eliminates a single precancerous skin growth. This is done to prevent it from developing into skin cancer. The growth may be removed using various methods such as cryotherapy (freezing), laser therapy, or topical medications.
820 services538 patients
Biopsy of related skin growth, first growth 11102
A biopsy of a skin growth involves taking a small sample of the growth to examine it under a microscope. This helps determine if the growth is harmful. The procedure is typically quick, with minimal discomfort. It's a crucial step in ensuring your skin's health.
423 services344 patients
Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more 99212
This is a routine check-up for patients who have previously seen the doctor. During this 10-19 minute visit, the doctor will review your health status, discuss any concerns, and manage ongoing treatments or medications. It's a chance to ensure your health is on track.
194 services146 patients

Physician Visit Costs CMS claims · ZIP area

Typical Medicare office-visit costs in the 85021 ZIP code area, from fee-for-service claims. These are area statistics, not this provider’s prices; actual charges vary by service and coverage.

New Patient
$85.89 typical visit price
range $55.44 – $168.60
Typical copayment $21.47 (range $13.86 – $42.15)
Most-billed visit code 99203
Established Patient
$69.24 typical visit price
range $17.72 – $137.41
Typical copayment $17.31 (range $4.43 – $34.35)
Most-billed visit code 99213
Amounts reflect what Medicare beneficiaries in this ZIP area are typically charged for office visits. Patients with other coverage should check their individual plans.

Medicare Quality Performance CMS QPP · MIPS

Performance in the CMS Quality Payment Program: the MIPS final score across four weighted categories, and the individual quality measures reported to Medicare.

63/100
MIPS Final ScoreMerit-based Incentive Payment System · CMS Quality Payment Program
Scored as part of a group practice
Quality55
Improvement Activities40
Cost36.68

Reported Quality Measures

Biopsy Follow-Up
Percentage of new patients whose biopsy results have been reviewed and communicated to the primary care/referring physician and patient by the performing physician
13%521 patients1/55-star benchmark: 100%
Care Plan
Percentage of patients aged 65 years and older who have an advance care plan or surrogate decision maker documented in the medical record that an advance care plan was discussed but the patient did not wish or was not able to name a surrogate decision maker…
70%1,507 patients3/55-star benchmark: 100%
e-Prescribing
At least one permissible prescription written by the MIPS eligible clinician is queried for a drug formulary and transmitted electronically using certified EHR technology.
96%5,361 patients4/55-star benchmark: 100%
Falls: Risk Assessment
Percentage of patients aged 65 years and older with a history of falls that had a risk assessment for falls completed within 12 months
100%45 patients5/55-star benchmark: 100%
Medication Reconciliation
The MIPS eligible clinician performs medication reconciliation for at least one transition of care in which the patient is transitioned into the care of the MIPS eligible clinician.
1%6,136 patients1/55-star benchmark: 100%
Medication Reconciliation Post-Discharge
The percentage of discharges from any inpatient facility (e.g. hospital, skilled nursing facility, or rehabilitation facility) for patients 18 years and older of age seen within 30 days following discharge in the office by the physician, prescribing…
100%1,475 patients
Oncology: Medical and Radiation - Pain Intensity Quantified
Percentage of patient visits, regardless of patient age, with a diagnosis of cancer currently receiving chemotherapy or radiation therapy in which pain intensity is quantified
4%24 patients1/55-star benchmark: 100%
Patient-Centered Surgical Risk Assessment and Communication
Percentage of patients who underwent a non-emergency surgery who had their personalized risks of postoperative complications assessed by their surgical team prior to surgery using a clinical data-based, patient-specific risk calculator and who received…
23%102 patients1/55-star benchmark: 100%
Patient-Specific Education
The MIPS eligible clinician must use clinically relevant information from CEHRT to identify patient-specific educational resources and provide access to those materials to at least one unique patient seen by the MIPS eligible clinician.
93%3,525 patients4/55-star benchmark: 100%
Pneumococcal Vaccination Status for Older Adults
Percentage of patients 65 years of age and older who have ever received a pneumococcal vaccine
39%1,507 patients2/55-star benchmark: 95%
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
Percentage of patients aged 18 years and older who were screened for tobacco use one or more times within 24 months AND who received tobacco cessation intervention if identified as a tobacco user
55%142 patients3/55-star benchmark: 100%
Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling
Percentage of patients aged 18 years and older who were screened for unhealthy alcohol use using a systematic screening method at least once within the last 24 months AND who received brief counseling if identified as an unhealthy alcohol user
87%1,518 patients4/55-star benchmark: 100%
Provide Patient Access
At least one patient seen by the MIPS eligible clinician during the performance period is provided timely access to view online, download, and transmit to a third party their health information subject to the MIPS eligible clinician's discretion to withhold…
93%3,525 patients4/55-star benchmark: 100%
Psoriasis: Clinical Response to Oral Systemic or Biologic Medications
Percentage of psoriasis vulgaris patients receiving oral systemic or biologic therapy who meet minimal physician-or patient- reported disease activity levels.
80%25 patients
Psoriasis: Tuberculosis (TB) Prevention for Patients with Psoriasis, Psoriatic Arthritis and Rheumatoid Arthritis Patients on a Biological Immune Response Modifier
Percentage of patients whose providers are ensuring active tuberculosis prevention either through yearly negative standard tuberculosis screening tests or are reviewing the patient's history to determine if they have had appropriate management for a recent or…
65%37 patients
Secure Messaging
For at least one unique patient seen by the MIPS eligible clinician during the performance period, a secure message was sent using the electronic messaging function of CEHRT to the patient (or the patient-authorized representative), or in response to a secure…
0%3,525 patients1/55-star benchmark: 79%
Tobacco Use and Help with Quitting Among Adolescents
The percentage of adolescents 12 to 20 years of age with a primary care visit during the measurement year for whom tobacco use status was documented and received help with quitting if identified as a tobacco user
96%242 patients
Providers report different measures because they deliver different services; reporting more or less information is not a reflection of quality. Star ratings appear only where CMS assigned them.

Other Providers at the Same Location NPPES 7

Providers registered at the same practice address, or within the immediate area, according to the NPPES registry.

Dermatology
2224 W NORTHERN AVE STE D300
PHOENIX, AZ 85021
Nurse Practitioner (Family)
2224 W NORTHERN AVE STE D300
PHOENIX, AZ 85021
Physician Assistant
2224 W NORTHERN AVE STE D300
PHOENIX, AZ 85021
Dermatology (MOHS-Micrographic Surgery)
2224 W NORTHERN AVE STE D300
PHOENIX, AZ 85021
Physician Assistant
2224 W NORTHERN AVE STE D300
PHOENIX, AZ 85021
Dermatology
2224 W NORTHERN AVE STE D300
PHOENIX, AZ 85021
Dermatology
2224 W NORTHERN AVE STE D300
PHOENIX, AZ 85021

Frequently Asked Questions NPPES & CMS

Common questions about this NPI record, answered from the official NPPES registry and CMS datasets shown on this page.

What is Glenn Zellman's NPI number?

The NPI number for Glenn Zellman is 1285611582. It was assigned to this individual provider in the NPPES registry on December 28, 2005.

Where is Glenn Zellman located?

Glenn Zellman practices at 2224 W Northern Ave Ste D300, Phoenix, AZ 85021. The listed phone number is (602) 277-1449.

What is Glenn Zellman's specialty?

The primary specialty registered for this NPI is Dermatology, specializing in Procedural Dermatology, with taxonomy code 207NS0135X.

Is Glenn Zellman enrolled in Medicare?

Yes. Glenn Zellman is registered in the Medicare PECOS system and accepts Medicare assignment, which means accepting the Medicare-approved amount as payment in full for covered services.

What insurance does Glenn Zellman accept?

Health plans from Blue Cross Blue Shield of Arizona and Oscar Health Plan, Inc. list Glenn Zellman as in-network in at least one marketplace plan. Coverage varies by plan and year; verify with the insurer or the provider before a visit.

When was this NPI record last updated?

The NPPES record for Glenn Zellman was last updated on October 24, 2018. NPI Profile syncs weekly with the NPPES registry data releases published by CMS. This NPI record was last updated 7 years ago. If this record has changed at CMS more recently, you can request an on-demand re-check against the live CMS registry, directly from this page.